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Incidence of phlebitis associated with the use of peripheral IV catheter 
and following catheter removal
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Objective: to investigate the incidence of phlebitis and its association with risk factors when 
using peripheral IV catheters (PIC) and following their removal - (post-infusion phlebitis) in 
hospitalized adults. Method: a cohort study of 171 patients using PIC, totaling 361 punctures. 
Sociodemographic variables and variables associated with the catheter were collected. Descriptive 
and analytical statistical analyses were performed. Results: average patient age was 56.96 and 
51.5% of the sample population was male. The incidence of phlebitis was 1.25% while using 
PIC, and 1.38% post-infusion.  The incidence of phlebitis while using PIC was associated with 
the length of time the catheter remained in place, whereas post-infusion phlebitis was associated 
with puncture in the forearm. Ceftriaxone, Clarithromycin and Oxacillin are associated with post-
infusion phlebitis. Conclusions: this study made it possible to investigate the association between 
risk factors and phlebitis during catheter use and following its removal. The frequency of post-
infusion phlebitis was larger than the incidence of phlebitis with the catheter in place, with 
Phlebitis Grade III and II being the most frequently found in each of these situations, respectively. 
Aspects related to post-infusion phlebitis can be explained, given the limited number of studies 
addressing this theme from this perspective.
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Introduction
Peripheral IV catheterization (PIC) is the most 
common invasive procedure performed on hospitalized 
patients(1). It requires manual dexterity and tec  hnical 
competence, knowledge of pharmaceutical therapy 
and familiarity with the anatomy and physiology of the 
vascular system. Because catheterization is done for 
different purposes and for different lengths of time, 
it represents a potential risk for a number of safety 
incidents, including microbial growth(2). However, 
regardless of the generating factor, local complications 
take the form of bruises, infiltration, leakage, catheter 
obstruction and phlebitis(3).
Phlebitis is an inflammation of the vein, which may 
bring with it pain, erythema, edema, hardening and/
or a palpable thread(4). Numerous factors can influence 
the development of phlebitis, such as inadequate 
technique when inserting the catheter, the patient’s 
clinical situation, the characteristics of the vein, drug 
incompatibility, tonus and pH of the medicine or solution, 
ineffective filtration, catheter diameter, size, length and 
material of manufacture; prolonged use(3,5-6).
Phlebitis can be split into four types (7-8): mechanical, 
when movement of the cannula inside the vein causes 
friction and inflammation, or when the cannula is too 
wide for the vein; chemical phlebitis, caused by the 
drug or fluid infused through the catheter, where factors 
such as pH and osmolality can significantly impact the 
incidence of phlebitis; bacterial, when bacteria penetrates 
the vein, starting as an inflammatory response to 
catheter insertion and subsequent colonization of the 
site by bacteria. Bacterial phlebitis can create serious 
complications due to the potential for the development 
of systemic sepsis(7). Post-infusion phlebitis normally 
appears 48 to 96 hours after the catheter is removed. 
Incidence is related especially to catheter material and 
the length of time the catheter remained in the patient’s 
vein(8).
Phlebitis manifests in four grades: Grade 1 - 
erythema around the puncture site, with or without local 
pain; Grade 2 - pain at the puncture site with erythema 
and/or edema and hardening; Grade 3: pain at the 
puncture site with erythema, hardening and a palpable 
venous cord; Grade 4: pain at the puncture site with 
erythema, hardening and a palpable venous cord that is 
> 1 cm, with purulent discharge.
A search of the LILACS and SCIELO databases 
between 2003 and 2014 using “phlebitis” as the search 
criterion found 16 and 18 articles respectively, of which 
four and five respectively were relevant to this analysis, 
including repetitions. Only one of these had post-infusion 
phlebitis as a topic.
The incidence of phlebitis in the literature varies 
quite a bit, with reports ranging from 61.2%(9) to 1.3%(10). 
The acceptable rate in any given population of patients 
is at most 5%(11). Thus, this study is justified due to the 
need to monitor and track the incidence of phlebitis in 
this teaching institution.
By analyzing the aspects above, we found gaps in 
the knowledge of the incidence of phlebitis, especially 
post-infusion phlebitis. Given the need for research 
on this topic and its importance as an indicator of the 
quality of nursing care, the goal of this study is to 
investigate the incidence of phlebitis and the association 
between risk factors and the incidence of phlebitis while 
using and following the removal of PIC (post-infusion 
phlebitis) in hospitalized adults.
Method
This is a cohort study. The study population is made 
up of 171 adult patients (aged 18 or over) hospitalized 
in a clinical hospitalization service of a university 
hospital in the city of Porto Alegre. Inclusion criteria 
were the use of peripheral intravenous catheter during 
hospitalization, assessment of the catheter in the first 12 
hours following insertion, and consent to participate in 
the study. Data was collected in October and November 
2013. The total patients in the sample allowed us to 
analyze 361 punctures for the placement of peripheral 
IV catheters. 
Data was collected by researchers using a tool with 
the following variables: sociodemographic data (age and 
gender), and data related to the PIC (date of puncture, 
location of insertion, catheter gauge (G), permanence 
(hours), and IV medication being administered. The 
location where the catheter was inserted was examined 
daily for the signs and symptoms of phlebitis. The 
location was monitored for up to 96 hours following 
catheter removal. Each PIC was analyzed individually 
as a new case. Phlebitis was categorized based on the 
moment symptoms appeared - before or after catheter 
removal, in which case it is known as post-infusion. 
The drugs followed during this study were those 
stated as being related to phlebitis(12): antibiotics 
(Clavulanic acid + Amoxicillin, Ampicillin, Amphotericin B, 
Aztreonam, Cephalotin, Cefazolin, Cefepime, Cefotaxime, 
Cefoxitin, Ceftazidime, Ceftriaxone, Cefuroxime, 
Clarithromycin, Erythromycin, Ertapenem, Imipinem, 
Levofloxacin, Meropenem, Oxacillin, Piperacillin + 
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Tazobactam, Sulfamethoxazole + Trimethoprim, 
Ticarcillin + Clavulanic Acid, Tigecycline, Vancomycin); 
anti-virals (Acyclovir, Ganciclovir); anti-arrhythmics 
(Amiodarone); anti-spasmodics (Dantrolene); hypnotic 
sedatives (Diazepam, Promethazine); vasoconstrictors 
(Dobutamine); vasolidators (Nitroglycerin); anti-
epileptics (Phenytoin, Phenobarbital); narcotic 
analgesics (Fentanyl, Meperidine); fat soluble vitamins 
(Phytomenadione); anti-anemics (Ferric Hydroxide); 
sedatives (Midazolam); antacids (Pantoprazole) and 
anti-mycotics (Voriconazole).
For a descriptive analysis of the data we used 
central tendency and dispersion measurements (mean 
and standard deviation) and proportions (percentages). 
For inferential analyses we used association tests (Chi-
squared and Fischer). We adopted a significance level 
of p<0.05. We used SPSS (Statistical Package for Social 
Sciences, SPSS Inc, Chicago), Windows version 17.0 for 
statistical data analysis. 
To calculate the incidence of phlebitis we divided 
the number of cases over the period by the number 
of patients/day with peripheral venous access in the 
same period, multiplied by 100(13). The average number 
of patients with PIC each day was 48, totaling 2,880 
patients over the 60-day period (two months). Incidence 
was calculated for phlebitis in general and phlebitis with 
catheter in place and following catheter removal. 
This Project was approved by the institution’s 
Research Ethics Committee (Protocol 07/03893). All of 
the patients signed the Free and Informed Consent Form. 
Whenever signs of phlebitis were identified, the nurse in 
charge was informed and measures implemented as per 
the unit’s SOP.
Results
The results of this study enabled a number of 
analyses that may contributed to understanding this 
complication resulting from the use of IV catheters. Most 
of the patients in the study were male, with an average 
age of 56.96 ±18.46, and median of 58 (18 - 98). Of the 
361 catheters assessed, the average time they remained 
in place was 3.37 ± 1.11 days, and the median 3 days 
(1 - 6). The average number of catheters per patient 
was 2.1 ± 1.62; 53.2% (n = 91) of the patients used 
a single catheter; 19.9% (n = 34) used two, 11.1% (n 
= 19) three; and 13.5% (n = 27) between four and 
eight catheters. There was no relationship between 
the number of catheters used and the incidence of or 
grade of phlebitis (p=0.572 and p=0.974 respectively), 
or following catheter removal (p=0.120 and p=0.569 
respectively). Table 1 shows the descriptive data of age 
and gender, and those related to the use of PICs.
Table 1 - Characteristics of age and gender related to 
PIC, location of puncture and drugs being used. Porto 
Alegre/RS, Brazil, 2014. n = 171 patients.
Characteristics N %
Age
≤ 57 83 48.5
≥ 58 88 51.5
Gender
Female 83 48.5
Male 88 51.5
Type of catheter (n=361)
Catheter with mandrel 361 100
Catheter gauge (n=361)
18 gauge 01 3.0
20 gauge 19 5.3
22 gauge 183 50.7
24 gauge 158 43.8
Catheter Maintenance (n=361)
Saline/Intermittent 279 77.3
Continuous saline 82 22.7
Time catheter remained in place (n=361)
Less than 72 hours 194 53.7
Over 72 hours 167 46.3
Location of Catheter Puncture (n=361)
Forearm 7 1.9
Elbow Pit 63 17.5
Arm/Writs 200 55.4
Hand 91 25.2
Drugs (n=361)
Antiviral 30 8.3
Antiarrhythmic 10 2.8
Vasoconstrictor 01 0.3
Antiepileptic 36 10.0
Antacid 06 1.7
Anti-anemic 20 5.5
Vitamin 18 5.0
Sedative/Analgesic 210 58.2
Antibiotic 184 51,0
Source: Study data
www.eerp.usp.br/rlae
4 Rev. Latino-Am. Enfermagem 2016;24:e2746.
Table 2 shows the frequency and trade of phlebitis 
during use and following removal of the PICs. The total 
incidence of phlebitis during use and following removal 
of the PICs was obtained by dividing the total number 
of phlebitis cases (76) by the total number of patients/
day using PIC over the period (2,880) and multiplying 
by 100. The result was 2.63%. Using the formula above, 
the incidence of phlebitis while using PICs (36) was 
1.25%, the incidence of post-infusion phlebitis (following 
catheter removal) (40) was 1.38%.
Table 3 shows the frequency of phlebitis while using 
PIC and following PIC removal, and the association of 
the incidence and grade of phlebitis with the risk factors 
monitored in this study. The length of time the catheter 
remained in place (≥ 72 hours) was associated with 
the incidence of phlebitis (p = 0.016), and puncture in 
the forearm was associated with post-infusion phlebitis 
(p = 0.054). Other factors, including grade, did not 
demonstrate any association with the incidence of the 
inflammation.
Table 2 - Descriptive analysis of phlebitis. Incidence, 
type and grade. Porto Alegre/RS, Brazil, 2014. n = 171 
patients.
N %
Signs of phlebitis while using PIC* (n=361)
Yes 36 10.0
No 325 90.0
Phlebitis grade while using PIC*  (n=36)
Grade I 25 69.4
Grade II 09 25.0
Grade III 02 5.5
Grade IV - -
Post-infusion (following PIC removal*) 
phlebitis (n=361) 
Yes 40 11.1
No 321 88.9
Phlebitis grade following PIC* removal 
(n=40)
Grade I 17 42.5
Grade II 22 55.0
Grade III 01 2.5
Grade IV - -
PIC* - Peripheral IV Catheter
 Table 3 - Frequency and association between age, gender and PIC insertion characteristics and the incidence of 
phlebitis during PIC use and following its catheter removal. Porto Alegre/RS, Brazil, 2014. n= 361 peripheral venous 
accesses.
Phlebitis while 
using PIC*
p
Phlebitis Grade while 
using PIC*
p
Post-infusion 
phlebitis
p
Post-infusion phlebitis 
Grade
p
No Yes I II III No Yes I II III
Gender
0.181‡ 0.680† 0.149‡Female
174 
(90.6)
18 
(9.4)
0.820†
15 
(83.3)
3 
(16.7)
- 169 
(88.0)
23 
(12.0)
12  
(52.2)
10 
(43.5)
1 (4.3)
Male 151 
(89.3)
18 
(10.7)
10 
(55.6)
6 
(33.3)
2 
(11.1)
152 
(89.9)
17 
(10.1)
5    
(29.4)
12 
(70.6)
-
Age
0.090‡ 0.709† 0.868‡
≤ 57
158 
(89.3)
19 
(10.7)
0.765†
16 
(84.2)
3 
(15.8)
- 159 
(89.8)
18 
(10.2)
7    
(38.9)
11 
(61.1)
-
≥ 58
167 
(90.8)
17 
(9.2)
9 
(52.9)
6 
(35.3)
2 
(11.8)
162 
(88.0)
22 
(12.0)
10   
(45.4)
11 
(50.0)
1 (4.5)
(continue...)
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Phlebitis while 
using PIC*
p
Phlebitis Grade while 
using PIC*
p
Post-infusion 
phlebitis
p
Post-infusion phlebitis 
Grade
p
No Yes I II III No Yes I II III
Puncture location
0.395† 0.801§ 0.054‡ 0.870§
Forearm
6     
(85.7)
1 
(14.3)
1 
(100)
- - 4     
(57.1)
3  
(42.9)
2 
(66.7)
1 
(33.3)
-
Elbow Pit
60 
(95.2)
3 (4.8)
3 
(100)
- - 59   
(93.7)
4 (6.3)
1    
(25.0)
3 
(75.0)
-
Arm/Wrist 178 
(89.0)
22 
(11.0)
14 
(63.6)
6 
(27.3)
2 (9.1)
176 
(88.0)
24 
(12.0)
11  
(45.8)
12 
(50.0)
1 (4.2)
Hand 81 
(89.0)
10 
(11.0)
7 
(70.0)
3 
(30.0)
- 82 
(90.1)
9 (9.9)
3    
(33.3)
6 
(66.7)
-
Tempo PIC in 
place
0.016† 0.595‡ 0.178† 1.000‡≤ 72h
182 
(93.8)
12 
(6.2)
8 
(66.7)
4 
(33.3)
- 168 
(86.6)
26 
(13.4)
11   
(42.3)
14 
(53.8)
1 (3.8)
>72h
143 
(85.6)
24 
(14.4)
17 
(70.8)
5 
(20.8)
2 (8.3)
153 
(91.6)
14 
(8.4)
6    
(42.9)
8 
(57.1)
-
Catheter 
Maintenance
0.776† 1.000‡ 1.000† 0.585‡Hydrolyzed
250 
(89.6)
29 
(10.4)
20 
(69.0)
7 
(24.1)
2 (6.9)
248 
(88.9)
31 
(11.1)
12  
(38.7)
18  
(58.1)
1 (3.2)
Saline 75 
(91.5)
7  
(8.5)
5  
(71.4)
2 
(28.6)
- 73 
(89.0)
9 
(11.0)
5
(55.6)
4 
(44.4)
-
Catheter gauge
0.251† - 0.057† 1.000‡
18 and 20 gauge
20 
(100)
- - - - 15 
(75.0)
5 
(25.0)
2    
(40.0)
3 
(60.0)
-
22 and 24 gauge
305 
(89.4)
36 
(10.6)
25 
(69.4)
9 
(25.0)
2 (5.6)
306 
(89.7)
35 
(10.3)
15  
(42.9)
19 
(54.3)
1 (2.9)
PIC* - Peripheral IV Catheter † Chi-squared with correction for continuity; ‡Fisher Test;  § Chi Squared test. Source: Study data 
(continue...)
Table 3 - (continuation)
Table 4 shows the results of the association of 
phlebitis during catheter use and following withdrawal 
and the use of drugs, by group. None of the groups of 
drugs studied showed any association with phlebitis. 
However, when we looked at specific drugs within each 
group, Ceftriaxone (n=7; 25%), Clarithromycin (n=7; 
28%) and Oxacillin (n=6; 46.2%) were associated with 
post-infusion phlebitis (p = 0.033; p = 0.014 and p ≤ 
0.001 respectively).
Table 4 - Frequency and association of drugs, by drug group, with the incidence of phlebitis while using and following 
removal of PICs. Porto Alegre/RS, Brazil, 2014. n= 361 peripheral venous accesses.
Phlebitis while 
using PIC* P
Phlebitis Grade while 
using PIC* P
Post-infusion 
phlebitis p
Post-infusion phlebitis 
Grade P
No Yes I II III No Yes I II III
Antiviral
No
287 
(89.7)
33 
(10.3)
0.745†
23 
(69.7)
8 
(24.2)
2  
(6.1)
1.000‡
281 
(87.8)
39 
(12.2)
0.108†
16 
(41.0)
22 
(56.4)
1 (2.6)
0.451‡
Yes 38 
(92.7)
3   
(7.3)
2 
(66.7)
1 
(33.3)
- 40 
(97.6)
1   
(2.4)
1  
(100)
- -
Antiarrhythmic
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Phlebitis while 
using PIC* P
Phlebitis Grade while 
using PIC* P
Post-infusion 
phlebitis p
Post-infusion phlebitis 
Grade P
No Yes I II III No Yes I II III
No
317 
(90.3)
34 
(9.7)
0.590†
25 
(73.5)
7 
(20.6)
2  
(5.9)
0.091‡
313 
(89.2)
38 
(10.8)
0.689†
16 
(42.1)
21 
(55.3)
1 (2.6)
1.000‡
Yes 8   
(80.0)
2 
(20.0)
- 2 
(100)
- 8   
(80.0)
2 
(20.0)
1 
(50.0)
1 
(50.0)
-
Vasoconstrictor
No
325 
(90.3)
35 
(9.7)
0.181†
24 
(68.6)
9 
(25.7)
2  
(5.7)
1.000‡
320 
(88.9)
40 
(11.1)
1.000†
17 
(42.5)
22 
(55.0)
1 (2.5)
-
Yes - 1  
(100)
1   
(100)
- - 1    
(100)
- - - -
Anti-epileptic
No
294 
(90.5)
31 
(9.5)
0.594†
20 
(64.5)
9   
(29)
2  
(6.5)
0.487‡
287 
(88.3)
38 
(11.7)
0.405†
16 
(42.1)
21 
(55.3)
1 (2.6)
1.000‡
Yes 31 
(86.1)
5 
(13.9)
5  
(100)
- - 34 
(94.4)
2 
  (5.6)
1 
(50.0)
1 
(50.0)
-
Antacids
No
319 
(89.9)
36 
(10.1) 0.893†
25 
(69.4)
9 
(25.0)
2 (5.6)
-
315 
(88.7)
40 
(11.3) 0.829†
17 
(42.5)
22 
(55.0)
1 (2.5)
-
Yes 6(100) - - - - 6(100) - - - -
Anti-anemic
No
309 
(90.9)
31 
(9.1)
0.248†
22 
(71.0)
8 
(25.8)
1 (3.2)
1.000‡
302 
(88.8)
38 
(11.2)
1.000†
17 
(44.7)
20 
(52.6)
1 (2.6)
0.520‡
Sim 16 
(76.2)
5 
(23.8)
3 
(60.0)
1 
(20.0)
1 
(20.0)
18 
(90.0)
2
(10.0)
- 2(100) -
Vitamins
No
309 
(90.1)
34 
(9.9)
1.000†
23 
(67.6)
9 
(26.5)
2  
(5.9)
1.000‡
304 
(88.6)
39 
(11.4)
0.703†
17 
(43.6)
21 
(53.8)
1 (2.6)
1.000‡
Yes 16 
(88.9)
2 
(11.1)
2  
(100)
- - 17 
(94.4)
1   
(5.6)
- 1  
(100)
-
Sedative/analgesic
No
135 
(89.4)
16 
(10.6)
0.875†
8 
(50.0)
6 
(37.5)
2 
(12.5)
0.062‡
137 
(90.7)
14 
(9.3)
0.448†
5 
(35.7)
9 
(64.3)
-
0.692‡
Yes 190 
(90.5)
20 
(9.5)
17 
(85.0)
3 
(15.0)
- 184 
(87.6)
26 
(12.4)
12 
(46.2)
13 
(50.0)
1 (3.8)
Antibiotics
No
163 
(93.1)
12 
(6.9)
0.132§
7 
(58.3)
4 
(33.3)
1  
(8.3)
0.486‡
160 
(91.4)
15 
(8.6)
0.281§
8 
(53.3)
6 
(40.0)
1 (6.7)
0.237‡
Yes 160
(87.0)
24 
(13.0)
18 
(75.0)
5 
(20.8)
1  
(4.2)
159 
(86.4)
25 
(13.6)
9 
(36.0)
16 
(64.0)
-
PIC* - Peripheral IV Catheter  † Chi-squared with correction for continuity; ‡Fisher Test;  § Chi Squared test. Source: Study data 
Discussion
The results of following 171 hospitalized patients 
using PIC enabled important analyses that can 
contribute to elucidating a number of aspects related 
to the incidence of phlebitis during intravenous therapy.
Regarding incidence, our study showed that 
total incidence (2.63%) and the incidence of phlebitis 
during PIC use (1.25%) and following catheter removal 
(1.38%) were within the international guidelines of the 
Intravenous Nurse Society(4), or less than 5%.  Compared 
to other studies(10,14), we found a wide variation in 
incidence, from 1.3% to 25.8%. This may be due to the 
different methods used and the specific limitations of 
each study.
We found a higher incidence of phlebitis after 
catheter removal (1.38%) than when the PIC was in 
place. Literature searches found no data comparing the 
Table 4 - (continuation)
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incidence of phlebitis during PIC use and after removal, 
which demonstrates the need for further studies on this 
topic, and the importance of monitoring the insertion site 
following catheter removal, a procedure that is not well 
disseminated and that makes a major difference in early 
identification of post-infusion phlebitis. This etiology is 
likely due to an inflammatory reaction starting close to 
the moment when the catheter was removed, with still 
with no visible symptoms. This should be considered in 
protocols so as not to underestimate the incidence or 
prevalence of phlebitis in the institution. 
Regarding Grade, the most frequent grade of 
phlebitis found during catheter use was Grade II, 
while Grade III was the most common in post-infusion 
phlebitis. Other studies corroborate these findings, with 
Grade I and II phlebitis being more common with PICs 
in place(3,6). We found no studies elucidating the Grade of 
phlebitis in post-infusion phlebitis, once again showing 
the need to investigate this topic and train nursing teams 
in the specificities of post-infusion phlebitis.
Of the 361 PIC punctures analyzed, the average 
permanence of the catheters was 3.37 ± 1.11 days, and 
the median 3 days, as recommended by ANVISA and 
the Royal College of Nursing,(15-16). Of the 167 catheters 
remaining for more than 72 hours, 24 patients (14.4%) 
showed the signs and symptoms of phlebitis. There was 
a significant (p=0.016) incidence of phlebitis compared 
to those who did not develop phlebitis. We found that the 
length of time the catheter remains in place influences 
the appearance of phlebitis, as found in another study, 
where the incidence of phlebitis was 62.5% when PICs 
remained in place longer than 72 hours.
Regarding gender and age, we found no statistical 
association with the incidence of phlebitis, unlike another 
study(8), claiming that one of the risk factors is being 
older than 65. However, in terms of gender it agrees 
with the study(9) that states there is no association 
between gender and phlebitis. 
Although the forearm is the preferred location 
for puncture due to its thick veins(6), only 1.9% of the 
punctures in this study were in the forearm. On the other 
hand, this location was of limiting significance (p=0.054) 
in terms of developing phlebitis, when compared to other 
locations. Another study found no significant association 
between part of the body and phlebitis(3), however the 
forearm was the location of puncture most often used by 
the nursing team.
When we analyzed the incidence of phlebitis 
against the gauge of the IV catheter, we found the most 
frequently used gauges were 22G and 24G (94.5%). We 
found limiting significance (p=0.057) in the incidence 
of post-infusion phlebitis when larger caliber catheters 
were used (18G and 20G). These findings coincide with 
those of another study(3), where 65% of the phlebitis 
cases were in patients in which 18G and 20G catheters 
had been used, unlike a previous study (17) that found a 
higher incidence of phlebitis (80.7%) when using 22G 
and 24G catheters. 
When we looked at the therapeutic class of 
the drugs we monitored, 51.0% of the patients used 
antibiotics while the PIC was in place, however we 
found no significant association with the incidence of 
phlebitis. Yet when looking at each drug individually, 
Ceftriaxone (p=0.033), Clarithromycin (p=0.014) and 
Oxacillin (p≤ 0.001) showed an association with post-
infusion phlebitis. Looking at the package leaflets for 
these drugs(18), we found that phlebitis was listed as 
a possible adverse reaction only for Ceftriaxone and 
Oxacillin, which is in agreement with the findings of the 
present study.  
Other medicines, while not showing any significant 
association, did have relevant results, such as amiodarone 
and ferric hydroxide, where we found a higher percentage 
of the signs of phlebitis in patients using these medicines 
(20.0% and 23.8% respectively) than in those who did 
not. We also found a higher percentage of post-infusion 
phlebitis among patients who used vancomycin (33.3%) 
than among not making use of this medication. In terms 
of the pH of the medicines, the more acidic the higher 
the risk of chemical phlebitis(19), which is in agreement 
with the findings regarding oxacillin (pH of 4.5 - 7.5)(20), 
however this does not explain the findings with other 
drugs.  
This study shows the importance of continued 
follow-up of the insertion site, as post-infusion phlebitis 
is not normally monitored by the institutions, and thus 
not computed in the incidence or prevalence rates 
used. Monitoring the insertion site (following catheter 
removal) is also important as phlebitis may result 
in longer hospitalization times as it is considered a 
clinical complication, and lead to a higher financial and 
psychological burden as a result of longer time spent in 
the hospital.
Conclusion
This study allowed us to look at the association 
between risk factors and the incidence of phlebitis 
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during the use and following the removal of peripheral 
IV catheters, showing the frequency of post-infusion 
phlebitis was larger than the incidence of phlebitis with 
the catheter in place, and that Grades III and II were 
the most frequent, respectively. Based on this finding, 
we infer there is a need to systematically monitor 
indicators in our searched for continued quality of care, 
and to compare rates in the different contexts of nursing 
practice. 
It is possible that a reduction in osmolarity resulting 
from the correct dilution when administering these drugs, 
as this institution follows the recommendations in the 
pharmacotherapeutic handbook, may have contributed 
to not finding a greater association between the drugs 
investigated and phlebitis. However, this aspect was 
not controlled in this study. We also found it difficult 
to analyze the insertion site when non-transparent 
adhesives were used to secure the catheter, or when 
non-allergenic tape was placed over the PIC site. This 
may have contributed to the evolution of higher Grades 
of phlebitis, showing the need for educational strategies 
to teach the staff how to properly use catheter, and to 
hold them in place with suitable material. 
Because the study patients were discharged from 
the hospital, we lost the ability to track the insertion 
sites following PIC removal, making it impossible to 
follow some of the patients for 96 hours, which may 
have contributed to a smaller number of post-infusion 
phlebitis cases.
This study helped elucidate aspects related to the 
incidence of post-infusion phlebitis. It is important to 
intensify education and training in early identification 
of phlebitis, and to monitor the insertion site after the 
catheter is removed, as few studies have addressed this 
topic from this perspective. 
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